Results 141 to 150 of about 44,987 (258)

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

History and impact of self-archiving

, 2005
Ana Maria Ramalho Correia and José Carlos Teixeira, Reforming scholarly publishing and knowledge communication: From the advent of the scholarly journal to the challenges of open access, Online Information Review, 29, 4 (2005) pp. 349-364. (Thanks to Charles W. Bailey, Jr.) Only this abstract is free online, at least so far.
openaire   +1 more source

HipScreen: a valid mobile app to measure hip migration in children with cerebral palsy in the community setting. [PDF]

Bone Jt Open
Khan AM, Amen J, Perkins O, Kafchitsas K, Cooke SJ, Kokkinakis M, HipScreen Study collaborators, Study collaborators, Ball L, King A, Billingham S, Bowpitt J, Webster A, Dhindsa S, Patel A, Clough L, Pieno O, Corps B, Heayberd R, Davenport S, Wicks C, Cadwgan J.   +21 more
europepmc   +1 more source

Adverse events in bedaquiline‐ and pretomanid‐based regimens for drug‐resistant tuberculosis from trial, implementation and pharmacovigilance studies

British Journal of Clinical Pharmacology, EarlyView.
Abstract The availability of safety data, particularly concerning adverse events (AEs) associated with the new shorter regimen for drug‐resistant tuberculosis (TB) containing a bedaquiline–pretomanid‐based regimen, is still limited. This systematic review aims to provide a comprehensive and updated analysis of AEs related to this new regimen by ...
Nisa Maria, Annisa Lazuardi Larasati, Indri Yuliani Hamdani, Jin‐Gun Cho, Jan‐Willem C. Alffenaar   +4 more
wiley   +1 more source

Self-archiving advice for authors

, 2006
Stevan Harnad, Cornell&#39;s Copyright Advice: Guide for the Perplexed Self-Archiver, <em> Open Access Archivangelism </em> , September 20, 2006.
openaire   +1 more source

Mapping Echocardiographic Practice in Emilia-Romagna: A Regional Healthcare Census. [PDF]

J Clin Med
Barbieri A, Mantovani F, Bursi F, Malaguti M, Fortuni F, Moderato L, Bartolacelli Y, Binno S, Malagoli A, Pavasini R, Pedone C, Suma S, Squeri A, Albini A, Vermi AC, Di Giannuario G, Laurito M, Li Calzi M, Navazio A, Moreo A, Di Salvo G, Carerj S.   +21 more
europepmc   +1 more source

Effect of oxycodone vs. morphine as first‐line opioid on new persistent opioid use after orthopaedic surgery: A prospective sequential cohort study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Background Postoperative opioids, intended for short‐term analgesia, contribute to new persistent opioid use in 1%–7% of patients, adversely affecting outcomes. Oxycodone may carry higher risk than morphine, though long‐term data are limited.
Eward J. Melis, Johanna E. Vriezekolk, Frédérique H. C. Bollen, Dirk E. Schrander, Arnt F. A. Schellekens, Bart J. F. van den Bemt   +5 more
wiley   +1 more source

Maximizing university research impact through self-archiving [PDF]

JCOM: Journal of Science Communication, 2003
Harnad Stevan
doaj  

Repeated intradermal lipopolysaccharide challenge responses in healthy volunteers: Implications for clinical pharmacology studies

British Journal of Clinical Pharmacology, EarlyView.
Aim Intradermal application of lipopolysaccharide (LPS), a Toll‐like receptor 4 agonist, induces a local inflammatory response and is used as a human challenge model to evaluate the pharmacodynamics of investigational medicinal products. While currently applied in a single, parallel‐group setting, alternative within‐subject designs involving repeated ...
Alexandra A. J. Sillé, Juliette A. van den Noort, Iva Lelios, Diana R. Pereira, Marzia A. Scelsi, Erica S. Klaassen, Philipp Schoenenberger, Naomi B. Klarenbeek, Pierre‐Eric Juif, Pascal Espie, Manon A. A. Jansen, Matthijs Moerland, Richard W. D. Welford   +12 more
wiley   +1 more source

PrEP at the site of action in cisgender and transgender women: A pharmacology study of blood and rectal CD4+ lymphocytes

British Journal of Clinical Pharmacology, EarlyView.
Background Female sex hormones used in feminizing hormone therapy (FHT) may influence activation and persistence of HIV pre‐exposure prophylaxis (PrEP) medications. The clinical relevance of this interaction remains unclear, particularly for transgender and cisgender women (TGW and CGW).
Elizabeth Hastie, Megha Srivasta, Edward R. Cachay, Leah Burke, Sara Gianella, Stephen Rawlings, Frank Z. Stanczyk, Craig Sykes, Angela D. M. Kashuba, Jill Blumenthal, Mackenzie L. Cottrell   +10 more
wiley   +1 more source